ALZHEIMER'S DISEASE PSYCHOSIS
Clinical trials for ALZHEIMER'S DISEASE PSYCHOSIS explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER'S DISEASE PSYCHOSIS trials appear
Sign up with your email to follow new studies for ALZHEIMER'S DISEASE PSYCHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New schizophrenia pill enters human safety testing
Disease control Recruiting nowThis Phase 1 trial tests the safety and tolerability of a new extended-release tablet called LY03020 in 40 Chinese adults, including healthy volunteers and people with stable schizophrenia. The drug is also being explored for psychosis related to Alzheimer's disease. Participants…
Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New pill aims to quiet hallucinations in Alzheimer's patients
Symptom relief Recruiting nowThis clinical trial tests a drug called ACP-204 to see if it can reduce hallucinations and delusions in people with Alzheimer's disease. The study will involve over 1,000 adults aged 55 to 95 who have Alzheimer's and psychosis. Participants will receive either ACP-204 or a placeb…
Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS
Phase: PHASE2, PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC